Skip to main content
Fig. 1 | The Journal of Headache and Pain

Fig. 1

From: Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study

Fig. 1

Mean Changes From Baseline in WPAI:M Absenteeism Subscores. Mean changes from baseline were calculated using LSMeans from a mixed model for repeated measures. The model included the following fixed effects: visit, country, stratification factor (monthly headache days at baseline: ≤14/> 14) and treatment as factors, baseline WPAI:M absenteeism subscore as a continuous covariate, baseline score-by-visit interaction, treatment-by-visit interaction, and stratum by-visit interaction. *P < 0.0001 vs placebo; †P < 0.001 vs placebo; ‡P < 0.01 vs placebo; §P < 0.05 vs placebo. WPAI:M, Work Productivity and Activity Impairment: Migraine

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us